Celadon Pharma up on permit for commercial supply of medicinal cannabis product
14/03/2023 15:21
** Shares of Celadon Pharmaceuticals Plc CEL.L surge as
much as 40% to 165p, their highest since Sept. 16, 2021
** The UK-based pharma firm focused on cannabis-based
medicines says its current home office licence successfully
updated, enabling start of commercial supply of its
tetrahydrocannabinol product
** Co recently got registered as a Good Manufacturing
Practices (GMP) manufacturer by the UK Medicines and Healthcare
products Regulatory Agency
** Including session's gains, stock has more than tripled
YTD
(Reporting by Aby Jose Koilparambil in Bengaluru)
((abyjose.koilparambil@thomsonreuters.com))